magnesium sulfate has been researched along with isosorbide-5-mononitrate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Budaj, A; Cedro, K; Collins, R; Fitzgerald, L; Flather, M; Hargreaves, A; Jacob, A; Kolettis, T; Millane, T; Pipilis, A | 1 |
2 trial(s) available for magnesium sulfate and isosorbide-5-mononitrate
Article | Year |
---|---|
ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative
Topics: Administration, Oral; Aged; Angiotensin-Converting Enzyme Inhibitors; Captopril; Delayed-Action Preparations; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Infusions, Intravenous; Isosorbide Dinitrate; Magnesium Sulfate; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Thrombolytic Therapy; Vasodilator Agents | 1995 |
Randomized controlled trial of oral captopril, of oral isosorbide mononitrate and of intravenous magnesium sulphate started early in acute myocardial infarction: safety and haemodynamic effects. ISIS-4 (Fourth International Study of Infarct Survival) Pilo
Topics: Captopril; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Magnesium Sulfate; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Pilot Projects; Research Design; Safety; Time Factors; Vasodilator Agents | 1994 |